Spencer Pharmaceutical Inc. Spencer Pharmaceutical Inc.

Spencer Pharmaceutical Inc.

SPPH

Rank in Stocks #35183
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms... Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$129.70
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade Spencer Pharmaceutical Inc. (SPPH)

Category

Healthcare
EPS for Spencer Pharmaceutical Inc. (SPPH)
EPS as of March 2004 TTM: $-1.34
According to Spencer Pharmaceutical Inc.'s latest financial reports, its current EPS (TTM) is $-1.34. At the end of 2003 the company had an EPS of $-1.00, an increase over its 2002 EPS of $-3.00.
EPS history for Spencer Pharmaceutical Inc. from 2001 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-1.34 34.00%
2003 $-1.00 -66.67%
2002 $-3.00 -7.69%
2001 $-3.25 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$1.69 -226.12%
US
$1.90 -241.70%
SE
$6.83 -610.04%
FR
$0.02 -101.46%
HK
$2.81 -309.78%
IT

Questions about Spencer Pharmaceutical Inc.'s earnings per share (EPS)

What is Spencer Pharmaceutical Inc.'s earnings per share (EPS)?

Spencer Pharmaceutical Inc.'s earnings per share (EPS) over the last twelve months is $-1.34, as of Mar 2004.

What was Spencer Pharmaceutical Inc.'s earnings per share (EPS) in 2003?

In 2003, Spencer Pharmaceutical Inc.'s earnings per share (EPS) was $-1.00, compared with $-3.00 in 2002.

How has Spencer Pharmaceutical Inc.'s earnings per share (EPS) changed since 2001?

From 2001 to 2003, Spencer Pharmaceutical Inc.'s earnings per share (EPS) was highest in 2003 ($-1.00) and lowest in 2001 ($-3.25).

How does Spencer Pharmaceutical Inc.'s earnings per share (EPS) compare with similar companies?

Spencer Pharmaceutical Inc.'s earnings per share (EPS) ($-1.34) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.